XML 368 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated statement of changes in equity (Parenthetical)
€ in Millions, £ in Millions
12 Months Ended
Dec. 31, 2022
EUR (€)
Dec. 31, 2021
EUR (€)
Dec. 31, 2020
EUR (€)
€ / shares
Jul. 07, 2022
EUR (€)
Increase through other effects of Unification [1]     € 0  
Hyperinflation adjustment € 514 € 280    
Other movements in equity (136) [2] 154 [3] (232) [3]  
Share capital reduction [4]   0    
Unilever Malaysia        
Premium paid for purchase of non-controlling interest     163  
Share premium account        
Increase through other effects of Unification [1]     73,364  
Other movements in equity [3]   (2)    
Share capital reduction [4]   20,626    
Other reserves        
Increase through other effects of Unification [1]     132  
Other movements in equity € (258) [2] (82) [3] € (44) [3]  
Welly Health        
Other movements in equity   € 82    
Nutrafol        
Non-controlling interest in acquiree       € 99
Nutrafol | Other reserves        
Non-controlling interest purchase option       € (269)
Unilever PLC        
Conversion rate for ordinary shares nominal value (in euro per GBP) | € / shares     5.143  
Increase through other effects of Unification     € 73,364  
[1] Includes the reduction of PLC’s share capital following the cessation of the Equalisation Agreement. Prior to Unification, a conversion rate of £1 = €5.143 was used in accordance with the Equalisation Agreement to translate PLC’s share capital. Following Unification, PLC’s share capital has been translated using the exchange rate at the date of Unification. To reflect the legal share capital of the PLC company, an increase to share premium of €73,364 million and a debit unification reserve for the same amount have been recorded as there is no change in the net assets of the Group. This debit is not a loss as a matter of law.
[2] Includes the following items related to the acquisition of Nutrafol: €(269) million non-controlling interest purchase option in other reserves and €99 million non-controlling interest recognised on acquisition.
[3] 2021 includes a hyperinflation adjustment of €280 million and €82 million related to the Welly acquisition. 2020 includes €163 million paid for purchase of the non-controlling interest in Unilever Malaysia.
[4] Share premium has been adjusted to reflect the legal share capital of the PLC company, which reduced by £18,400 million following court approval on 15 June 2021.